Thank You Sites!
We are grateful for the work you do every day to improve human health.
Read More | Free eLearning
Upcoming Virtual Symposium
Gene Therapy Research in the Age of COVID-19: Study Startup Success for Infectious Disease, Oncology, and Rare Disease Research
Register Now
IRB Services
IBC Services
GxP/HRP Consulting Services
Canadian Review
Trust Advarra’s integrated solutions and collaborative approach to make your research altogether better.
Advarra® provides institutional review board (IRB), institutional biosafety committee (IBC) and GxP/HRP research compliance consulting services with unprecedented clarity.
Advarra recently acquired Forte, the market-leading provider of clinical technology solutions including OnCore. Learn more
Our Latest Updates
Discover What’s Happening at Advarra
IRB Advisor Features Advarra Executive James Riddle in Article About Research Post-COVID-19
IRB Advisor interviewed James Riddle, Advarra VP of Institutional Services, for its article “What Happens to Human Research in the...
sIRB 101: An Introduction to Relying on an External IRB
Federal mandates for single IRB (sIRB) review of multisite research have ushered in a new era of sIRB oversight. Multisite research funded by NIH, HHS, and other agencies must now…
Safety Precautions for Laboratory Research With COVID-19 Specimens
The current global pandemic has brought biosafety to the spotlight. Biosafety practices must be customized to the proposed research as well as the existing facility and local regulatory requirements.